XANTHOPOULOS KLEANTHIS G Insider Trading

Get the latest insider transactions of XANTHOPOULOS KLEANTHIS G. XANTHOPOULOS KLEANTHIS G is Director in APRICUS BIOSCIENCES, INC. ($APRI) and President and CEO in Regulus Therapeutics Inc. ($RGLS) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN). Discover the current value of XANTHOPOULOS KLEANTHIS G shares.

Address: C/O ANADYS PHARMACEUTICALS, INC. 9050 CAMINO SANTA FE SAN DIEGO 92121CA

XANTHOPOULOS KLEANTHIS G is Insider in these Companies

TickerCompany NameCurrent and Previous PositionsTotal SharesCurrent Value ($)
RGLSRegulus Therapeutics Inc.President and CEO3,7055,187.00
ZSANZosano Pharma Corp8,59610,315.20
SEELSEELOS THERAPEUTICS, INC.Director24,57564,632.25

Insider Trading Transactions of XANTHOPOULOS KLEANTHIS G

DateTickerCompanyOwnerRelationship Transaction Cost ($) Shares Transaction Value ($) Total Shares
Jun 29 2020ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GBuy0.007,50008,596
Jun 05 2020ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GDirectorOption Exercise1.0115,00015,15015,000
Jul 18 2019ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GDirectorOption Exercise2.341,5003,5101,500
Jun 01 2018ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GDirectorOption Exercise4.2425,000106,00025,000
Mar 02 2018ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GDirectorOption Exercise0.5330,00015,90030,000
Jan 08 2018APRIAPRICUS BIOSCIENCES, INC.XANTHOPOULOS KLEANTHIS GDirectorOption Exercise2.1150,000105,50050,000
Jan 06 2017APRIAPRICUS BIOSCIENCES, INC.XANTHOPOULOS KLEANTHIS GDirectorBuy0.0015,000024,575
Nov 04 2016ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GDirectorOption Exercise0.5820,00011,50020,000
Oct 03 2016APRIAPRICUS BIOSCIENCES, INC.XANTHOPOULOS KLEANTHIS GDirectorBuy0.3416,9975,75095,746
Aug 22 2016ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GDirectorBuy1.3215,92021,01421,920
Aug 22 2016ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GDirectorOption Exercise1.4515,92023,08415,920
Aug 22 2016ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GDirectorOption Exercise1.5515,92024,67615,920
Jul 01 2016APRIAPRICUS BIOSCIENCES, INC.XANTHOPOULOS KLEANTHIS GDirectorBuy0.4014,3935,75078,749
Apr 07 2016APRIAPRICUS BIOSCIENCES, INC.XANTHOPOULOS KLEANTHIS GDirectorBuy0.588,6215,00064,356
Jan 05 2016APRIAPRICUS BIOSCIENCES, INC.XANTHOPOULOS KLEANTHIS GDirectorOption Exercise0.9750,00048,50050,000
Apr 21 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOBuy0.3873,92928,09377,634
Apr 21 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOSell16.9473,9291,252,0023,705
Apr 21 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOBuy0.3866,07125,10769,776
Apr 21 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOSell16.8566,0711,113,5143,705
Apr 21 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOBuy0.3860,00022,80063,705
Apr 21 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOSell17.7360,0001,063,9803,705
Apr 21 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOOption Exercise0.3873,92928,093134,358
Apr 21 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOOption Exercise0.3866,07125,10768,287
Apr 21 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOOption Exercise0.3860,00022,8008,287
Apr 02 2015ZSANZosano Pharma CorpXANTHOPOULOS KLEANTHIS GDirectorBuy0.006,00006,000
Mar 05 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOBuy0.3889,23033,90791,696
Mar 05 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOSell20.0665,6141,316,51226,082
Mar 05 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOSell20.8123,616491,5512,466
Mar 05 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOOption Exercise0.3889,23033,907208,287
Mar 03 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOBuy0.3870272,536
Mar 03 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOSell19.50701,3652,466
Mar 03 2015RGLSRegulus Therapeutics Inc.XANTHOPOULOS KLEANTHIS GPresident and CEOOption Exercise0.387027297,517